Profile
Kathleen A.
McGowan worked as a CAO, Finance Director & Controller at Windtree Therapeutics, Inc. from 2004 to 2008.
Prior to that, she was the Director-Financial Analysis at Claneil Enterprises, Inc. from 2000 to 2004.
She also worked at Johnson & Johnson as a Principal from 1983 to 1995.
Additionally, she held positions as a Controller at The Liposome Co., Inc. and Brand Pharm, and as a Principal at Ortho-McNeil Pharmaceutical LLC.
Later in her career, she worked as the Vice President-Finance at Tobira Therapeutics, Inc. from 2008 to 2012, and as the Chief Financial Officer at VaxInnate Corp.
Ms. McGowan received her undergraduate degree from Drexel University and her MBA from Fairleigh Dickinson University.
Former positions of Kathleen A. McGowan
| Companies | Position | End |
|---|---|---|
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| WINDTREE THERAPEUTICS, INC. | Director of Finance/CFO | 2008-01-02 |
Claneil Enterprises, Inc.
 Claneil Enterprises, Inc. MiscellaneousMiscellaneous Claneil Enterprises, Inc. operated as an investment holding company that focuses on office equipment and supplies. The company was founded in 1971 and was headquartered in Plymouth Meeting, PA. | Corporate Officer/Principal | 2003-12-31 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 1994-12-31 |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Director of Finance/CFO | - |
Training of Kathleen A. McGowan
| Drexel University | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
The Liposome Co., Inc.
 The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Health Technology |
Brand Pharm
 Brand Pharm Advertising/Marketing ServicesCommercial Services Brand Pharm provides advertising and marketing services for pharmaceutical product manufacturers. The company was founded by Wayne K. Nelson in 1987 and is headquartered in New York, NY. | Commercial Services |
Claneil Enterprises, Inc.
Claneil Enterprises, Inc. MiscellaneousMiscellaneous Claneil Enterprises, Inc. operated as an investment holding company that focuses on office equipment and supplies. The company was founded in 1971 and was headquartered in Plymouth Meeting, PA. | Miscellaneous |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Health Technology |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Health Technology |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
- Stock Market
- Insiders
- Kathleen A. McGowan